Bom VJ - Search Results

1

Coagulation factor abnormalities as possible thrombotic risk factors after Fontan operations.

Cromme-Dijkhuis AH, Henkens CM, Bijleveld CM, Hillege HL, Bom VJ, van der Meer J. Cromme-Dijkhuis AH, et al. Among authors: bom vj. Lancet. 1990 Nov 3;336(8723):1087-90. doi: 10.1016/0140-6736(90)92568-3. Lancet. 1990. PMID: 1977979

2

The clinical expression of hereditary protein C and protein S deficiency: a relation to clinical thrombotic risk factors and to levels of protein C and protein S?

Henkens CM, van der Meer J, Hillege JL, van der Schaaf W, Bom VJ, Halie MR. Henkens CM, et al. Among authors: bom vj. Blood Coagul Fibrinolysis. 1993 Aug;4(4):555-62. doi: 10.1097/00001721-199308000-00005. Blood Coagul Fibrinolysis. 1993. PMID: 8218852

3

Severe bleeding caused by an inhibitor to coagulation factor V: a case report.

Smid WM, de Wolf JT, Nijland JH, Bom VJ, van der Meer J. Smid WM, et al. Among authors: bom vj. Blood Coagul Fibrinolysis. 1994 Feb;5(1):133-7. doi: 10.1097/00001721-199402000-00015. Blood Coagul Fibrinolysis. 1994. PMID: 8180333

4

Plasma levels of protein S, protein C, and factor X: effects of sex, hormonal state and age.

Henkens CM, Bom VJ, Van der Schaaf W, Pelsma PM, Sibinga CT, de Kam PJ, van der Meer J. Henkens CM, et al. Among authors: bom vj. Thromb Haemost. 1995 Nov;74(5):1271-5. Thromb Haemost. 1995. PMID: 8607108

5

Sensitivity to activated protein C; influence of oral contraceptives and sex.

Henkens CM, Bom VJ, Seinen AJ, van der Meer J. Henkens CM, et al. Among authors: bom vj. Thromb Haemost. 1995 Mar;73(3):402-4. Thromb Haemost. 1995. PMID: 7667823

6

Coagulation and fibrinolytic responses of human peritoneal fluid and plasma to bacterial peritonitis.

van Goor H, Bom VJ, van der Meer J, Sluiter WJ, Bleichrodt RP. van Goor H, et al. Among authors: bom vj. Br J Surg. 1996 Aug;83(8):1133-5. doi: 10.1002/bjs.1800830833. Br J Surg. 1996. PMID: 8869327 Free article.

7

Lowered APC-sensitivity ratio related to increased factor VIII-clotting activity.

Henkens CM, Bom VJ, van der Meer J. Henkens CM, et al. Among authors: bom vj. Thromb Haemost. 1995 Oct;74(4):1198-9. Thromb Haemost. 1995. PMID: 8560436 No abstract available.

8

Association of smooth muscle cell tissue factor with caveolae.

Mulder AB, Smit JW, Bom VJ, Blom NR, Ruiters MH, Halie MR, van der Meer J. Mulder AB, et al. Among authors: bom vj. Blood. 1996 Aug 15;88(4):1306-13. Blood. 1996. PMID: 8695848 Free article.

9

Absolute risk of venous and arterial thromboembolism in thrombophilic families is not increased by high thrombin-activatable fibrinolysis inhibitor (TAFI) levels.

Folkeringa N, Coppens M, Veeger NJ, Bom VJ, Middeldorp S, Hamulyak K, Prins MH, Büller HR, van der Meer J. Folkeringa N, et al. Among authors: bom vj. Thromb Haemost. 2008 Jul;100(1):38-44. doi: 10.1160/TH07-11-0659. Thromb Haemost. 2008. PMID: 18612536

10

Anti-streptokinase antibodies inhibit fibrinolytic effects of anistreplase in acute myocardial infarction.

Brügemann J, van der Meer J, Bom VJ, van der Schaaf W, de Graeff PA, Lie KI. Brügemann J, et al. Among authors: bom vj. Am J Cardiol. 1993 Aug 15;72(5):462-4. doi: 10.1016/0002-9149(93)91143-6. Am J Cardiol. 1993. PMID: 8352192 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

37 results

Search Page

Filters